| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |